Pulike Biological Engineering
医疗健康 · 生物科技
Pulike Biological Engineering, Inc. engages in the research, development, production, and sale of veterinary biological products, chemical drugs, and traditional Chinese veterinary drugs. The company offers vaccines, antibodies, and medicines for swine and poultry, as well as disinfectants. Pulike Biological Engineering, Inc. was founded in 1995 and is headquartered in Luoyang, China.
MARKET 市值 3.54B CNY PE 20.4x
52W ¥9.56 – ¥15.79
EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG — 营收 YoY -10.5%
▼ ROE 6.2% 营业利润率 15.6% 净利润率 16.3%
ANALYST 股息率 5.93%